Cosentyx — Medical Mutual

Initial criteria

• Patient age ≥ 2 years
• Prescribed by or in consultation with a rheumatologist or dermatologist

Reauthorization criteria

• Patient has been established on therapy for at least 6 months AND
• Patient experienced beneficial clinical response from baseline by objective measure OR improvement in at least one symptom such as less joint pain, decreased stiffness, improved function, decreased swelling

Approval duration

initial 6 months; reauth 1 year